Back

Arizona Osteopathic Medical Association

  • Contraception
  • Estrogens
  • Intrauterine Devices
  • Lidocaine
  • Progestins

Beyond the pill: A physician s guide to next-gen contraception, IUD innovations, and lifespan hormone therapy

Learning objectives: 1. Evaluate and Prescribe Next-Gen Contraception: Compare the clinical profiles of new estrogen and progestin-only delivery systems (including Estetrol, Annovera, and Twirla) while applying the 2024 CDC Medical Eligibility Criteria to diverse patient populations. 2. Implement Evidence-Based IUD Pain Management: Demonstrate the technical application of paracervical blocks and lidocaine sprays for IUD insertions, in accordance with the 2025 ACOG Clinical Consensus on procedural comfort. 3. Analyze Lifespan Hormone Benefits: Identify the “window of opportunity” for initiating hormone therapy to optimize bone density and cardiovascular health, while leveraging the November 2025 FDA labeling updates to counsel patients on the safety of localized estrogen.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

No specific specialties targeted.

Pricing

Fee varies

This provider typically $30–40

See fees on thecmecenter.org

Listed by the provider

  • Conference / congress
  • Credit · Up to 1 credit
  • Fee varies · this provider typically $30–40
  • Released
    Aug 17, 2026
  • Last day to claim credit
    Mar 21, 2029 2 years left